December deal flurry rolls on with Genentech-Caris cancer collab worth up to $1.1B
December deal flurry rolls on with Genentech-Caris cancer collab worth up to $1.1B
Body unavailable. Use the original source.
December deal flurry rolls on with Genentech-Caris cancer collab worth up to $1.1B
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.